Sensitive Detection of Pathway Perturbations in Cancers

Simple item page
dc.contributor.authorRivera, Corban G.en
dc.contributor.authorTyler, Brett M.en
dc.contributor.authorMurali, T. M.en
dc.contributor.departmentComputer Scienceen
dc.contributor.departmentFralin Life Sciences Instituteen
dc.contributor.departmentInstitute for Critical Technology and Applied Science (ICTAS)en
dc.date.accessioned2012-03-21T12:21:25Zen
dc.date.available2012-03-21T12:21:25Zen
dc.date.issued2012-03-21en
dc.date.updated2012-03-21T12:21:25Zen
dc.description.abstractBackground The normal functioning of a living cell is characterized by complex interaction networks involving many different types of molecules. Associations detected between diseases and perturbations in well-defined pathways within such interaction networks have the potential to illuminate the molecular mechanisms underlying disease progression and response to treatment. Results In this paper, we present a computational method that compares expression profiles of genes in cancer samples to samples from normal tissues in order to detect perturbations of pre-defined pathways in the cancer. In contrast to many previous methods, our scoring function approach explicitly takes into account the interactions between the gene products in a pathway. Moreover, we compute the sub-pathway that has the highest score, as opposed to merely computing the score for the entire pathway. We use a permutation test to assess the statistical significance of the most perturbed sub-pathway. We apply our method to 20 pathways in the Netpath database and to the Global Cancer Map of gene expression in 18 cancers. We demonstrate that our method yields more sensitive results than alternatives that do not consider interactions or measure the perturbation of a pathway as a whole. We perform a sensitivity analysis to show that our approach is robust to modest changes in the input data. Our method confirms numerous well-known connections between pathways and cancers. Conclusions Our results indicate that integrating differential gene expression with the interaction structure in a pathway is a powerful approach for detecting links between a cancer and the pathways perturbed in it. Our results also suggest that even well-studied pathways may be perturbed only partially in any given cancer. Further analysis of cancer-specific sub-pathways may shed new light on the similarities and differences between cancers.en
dc.description.versionPublished versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationBMC Bioinformatics. 2012 Mar 21;13(Suppl 3):S9en
dc.identifier.doihttps://doi.org/10.1186/1471-2105-13-S3-S9en
dc.identifier.urihttp://hdl.handle.net/10919/18634en
dc.language.isoenen
dc.relation.ispartofACM Conference on Bioinformatics, Computational Biology and Biomedicine 2011 (ACM-BCB) Chicago, IL, USA. 1-3 August 2011en
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.rights.holderet al.; licensee BioMed Central Ltd.en
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en
dc.titleSensitive Detection of Pathway Perturbations in Cancersen
dc.title.serialBMC Bioinformaticsen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten

Files

Original bundle
Now showing 1 - 2 of 2
Name:
1471-2105-13-S3-S9.xml
Size:
106.54 KB
Format:
Extensible Markup Language
Download
Thumbnail Image
Name:
1471-2105-13-S3-S9.pdf
Size:
1002.78 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.5 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Journal Articles, BioMed Central and SpringerOpen
Scholarly Works, Computer Science
Scholarly Works, Fralin Life Sciences Institute
Scholarly Works, Institute for Critical Technology and Applied Science (ICTAS)